0001859061-23-000006.txt : 20230517
0001859061-23-000006.hdr.sgml : 20230517
20230517071318
ACCESSION NUMBER: 0001859061-23-000006
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230512
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: A2A Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001859061
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40335
FILM NUMBER: 23929618
BUSINESS ADDRESS:
STREET 1: 59 5TH AVE
CITY: NEW YORK
STATE: NY
ZIP: 10003
BUSINESS PHONE: (914) 841-8818
MAIL ADDRESS:
STREET 1: 59 5TH AVE
CITY: NEW YORK
STATE: NY
ZIP: 10003
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biomea Fusion, Inc.
CENTRAL INDEX KEY: 0001840439
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 MIDDLEFIELD ROAD
STREET 2: 4TH FLOOR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: (650) 980-9099
MAIL ADDRESS:
STREET 1: 900 MIDDLEFIELD ROAD
STREET 2: 4TH FLOOR
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0407
4
2023-05-12
0
0001840439
Biomea Fusion, Inc.
BMEA
0001859061
A2A Pharmaceuticals, Inc.
59 5TH AVE
NEW YORK
NY
10003
0
0
1
0
0
Common Stock
2023-05-12
2023-05-12
4
S
0
25000
33.84
D
3625000
D
A total of 25,000 shares were sold at an average price of 33.84 in multiple transactions in a range of 33.50 to 34.50. Details of the specific transactions are available upon request.
Edward Painter
2023-05-17